What is the evidence for using an SSRI plus Lamotrigine in treatment-resistant OCD?

Evidence shows that augmenting SSRIs with lamotrigine can significantly reduce OCD symptoms in treatment-resistant cases, suggesting it as a viable therapeutic strategy.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-02
DOI
https://doi.org/10.5281/zenodo.23889401
Primary Topic
Obsessive-Compulsive Spectrum Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What is the evidence for using an SSRI plus Lamotrigine in treatment-resistant OCD?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Obsessive-Compulsive Spectrum Disorders
article

What is the evidence for using an SSRI plus Lamotrigine in treatment-resistant OCD?

Tripdatabase
article en

Abstract

Evidence shows that augmenting SSRIs with lamotrigine can significantly reduce OCD symptoms in treatment-resistant cases, suggesting it as a viable therapeutic strategy.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 11%
Obsessive-Compulsive Spectrum Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
What is the evidence for using an SSRI plus Lamotrigine in treatment-resistant OCD? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS